Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 5/2018

01.10.2018 | Research Article

Medication-related problems among adult chronic kidney disease patients in a sub-Saharan tertiary hospital

verfasst von: Lisper Wangeci Njeri, William Otieno Ogallo, David Gitonga Nyamu, Sylvia Adisa Opanga, Alfred Rugendo Birichi

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Chronic kidney disease (CKD) patients are prone to medication-related problems (MRPs). Few studies address the clinical relevance of MRPs among CKD patients in sub-Saharan Africa.

Objective

To investigate the frequency and predictors of MRPs among adult CKD patients treated at a tertiary care facility in an urban sub-Saharan setting.

Setting

Kenyatta National Hospital in Nairobi, Kenya.

Method

A cross-sectional study involving 60 adult patients with CKD was carried out. Data were collected through structured interviews and patient chart reviews between April 2016 and June 2016. MRPs identified from the collected data were classified according to Hepler and Strand classification. The frequencies of the identified MRPs were computed and logistic regression used to investigate the associations between the MRPs and covariates in the data. Main outcome measures: frequencies and predictors of MRPs.

Results

271 MRPs were identified. The commonest MRPs were drug interactions (21.8%), indication without drug (18.1%) and medication non-adherence (15.5%). Compared to patients with CKD stage 3, patients with CKD stage 4 were 5.9 times more likely to have an improper drug selection and 4.7 times more likely to experience overdosage. Other significant predictors of MRPs were the number of medications per prescription and the number of comorbidities per patient.

Conclusion

This study found a high frequency of MRPs among patients with chronic kidney disease receiving care in urban sub-Saharan tertiary hospital settings. The predictors of MRPs among CKD patients in this setting are likely to be multifactorial and include the CKD stage, polypharmacy, and comorbidities.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258–70.CrossRef Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258–70.CrossRef
2.
Zurück zum Zitat Schoolwerth AC, Engelgau MM, Hostetter TH, Rufo KH, Chianchiano D, McClellan WM, et al. Chronic kidney disease: a public health problem that needs a public health action plan. Prev Chronic Dis. 2006;3(2):A57-A. Schoolwerth AC, Engelgau MM, Hostetter TH, Rufo KH, Chianchiano D, McClellan WM, et al. Chronic kidney disease: a public health problem that needs a public health action plan. Prev Chronic Dis. 2006;3(2):A57-A.
5.
Zurück zum Zitat Naicker S. Burden of end-stage renal disease in sub-Saharan Africa. Clin Nephrol. 2010;74(Suppl 1):S13–6. Naicker S. Burden of end-stage renal disease in sub-Saharan Africa. Clin Nephrol. 2010;74(Suppl 1):S13–6.
6.
Zurück zum Zitat Arogundade FA, Barsoum RS. CKD prevention in sub-Saharan Africa: a call for governmental, nongovernmental, and community support. Am J Kidney Dis. 2008;51(3):515–23.CrossRef Arogundade FA, Barsoum RS. CKD prevention in sub-Saharan Africa: a call for governmental, nongovernmental, and community support. Am J Kidney Dis. 2008;51(3):515–23.CrossRef
7.
Zurück zum Zitat Cardone KE, Bacchus S, Assimon MM, Pai AB, Manley HJ. Medication-related problems in CKD. Adv Chronic Kidney Dis. 2010;17(5):404–12.CrossRef Cardone KE, Bacchus S, Assimon MM, Pai AB, Manley HJ. Medication-related problems in CKD. Adv Chronic Kidney Dis. 2010;17(5):404–12.CrossRef
8.
Zurück zum Zitat Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–43.PubMed Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–43.PubMed
9.
Zurück zum Zitat Belaiche S, Romanet T, Allenet B, Calop J, Zaoui P. Identification of drug-related problems in ambulatory chronic kidney disease patients: a 6-month prospective study. J Nephrol. 2012;25(5):782–8.CrossRef Belaiche S, Romanet T, Allenet B, Calop J, Zaoui P. Identification of drug-related problems in ambulatory chronic kidney disease patients: a 6-month prospective study. J Nephrol. 2012;25(5):782–8.CrossRef
10.
Zurück zum Zitat Patel HR, Pruchnicki MC, Hall LE. Assessment for chronic kidney disease service in high-risk patients at community health clinics. Ann Pharmacother. 2005;39(1):22–7.CrossRef Patel HR, Pruchnicki MC, Hall LE. Assessment for chronic kidney disease service in high-risk patients at community health clinics. Ann Pharmacother. 2005;39(1):22–7.CrossRef
11.
Zurück zum Zitat Hassan Y, Al-Ramahi RJ, Aziz NA, Ghazali R. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease. Ann Pharmacother. 2009;43:1598–605.CrossRef Hassan Y, Al-Ramahi RJ, Aziz NA, Ghazali R. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease. Ann Pharmacother. 2009;43:1598–605.CrossRef
12.
Zurück zum Zitat Belaiche S, Romanet T, Bell R, Calop J, Allenet B, Zaoui P. Pharmaceutical care in chronic kidney disease: experience at Grenoble University Hospital from 2006 to 2010. J Nephrol. 2012;25(4):558–65.CrossRef Belaiche S, Romanet T, Bell R, Calop J, Allenet B, Zaoui P. Pharmaceutical care in chronic kidney disease: experience at Grenoble University Hospital from 2006 to 2010. J Nephrol. 2012;25(4):558–65.CrossRef
13.
Zurück zum Zitat Marquito AB, Fernandes NMDS, Colugnati FAB, Paula RBD. Identifying potential drug interactions in chronic kidney disease patients. Jornal brasileiro de nefrologia: ʹorgão oficial de Sociedades Brasileira e Latino-Americana de Nefrologia. 2014;36(1):26–34.CrossRef Marquito AB, Fernandes NMDS, Colugnati FAB, Paula RBD. Identifying potential drug interactions in chronic kidney disease patients. Jornal brasileiro de nefrologia: ʹorgão oficial de Sociedades Brasileira e Latino-Americana de Nefrologia. 2014;36(1):26–34.CrossRef
14.
Zurück zum Zitat Rama M, Viswanathan G, Acharya LD, Attur RP, Reddy PN, Raghavan SV. Assessment of drug–drug interactions among renal failure patients of nephrology ward in a South Indian Tertiary Care Hospital; 2012, p. 63–8. Rama M, Viswanathan G, Acharya LD, Attur RP, Reddy PN, Raghavan SV. Assessment of drug–drug interactions among renal failure patients of nephrology ward in a South Indian Tertiary Care Hospital; 2012, p. 63–8.
15.
Zurück zum Zitat Stemer G, Lemmens-Gruber R. Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review. BMC Nephrol. 2011;12:35.CrossRef Stemer G, Lemmens-Gruber R. Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review. BMC Nephrol. 2011;12:35.CrossRef
16.
Zurück zum Zitat Manley HJ, Cannella CA, Bailie GR, Peter WLS. Medication-related problems in ambulatory hemodialysis patients: a pooled analysis. Am J Kidney Dis. 2005;46(4):669–80.CrossRef Manley HJ, Cannella CA, Bailie GR, Peter WLS. Medication-related problems in ambulatory hemodialysis patients: a pooled analysis. Am J Kidney Dis. 2005;46(4):669–80.CrossRef
17.
Zurück zum Zitat Manley HJ, McClaran ML, Overbay DK, Wright MA, Reid GM, Bender WL, et al. Factors associated with medication-related problems in ambulatory hemodialysis patients. Am J Kidney Dis. 2003;41(2):386–93.CrossRef Manley HJ, McClaran ML, Overbay DK, Wright MA, Reid GM, Bender WL, et al. Factors associated with medication-related problems in ambulatory hemodialysis patients. Am J Kidney Dis. 2003;41(2):386–93.CrossRef
18.
Zurück zum Zitat Magacho EJC, Ribeiro LC, Chaoubah A, Bastos MG. Adherence to drug therapy in kidney disease. Braz J Med Biol Res. 2011;44(3):258–62.CrossRef Magacho EJC, Ribeiro LC, Chaoubah A, Bastos MG. Adherence to drug therapy in kidney disease. Braz J Med Biol Res. 2011;44(3):258–62.CrossRef
20.
Zurück zum Zitat Graffar M. Modern epidemiology; 1971. p. 661–9. Graffar M. Modern epidemiology; 1971. p. 661–9.
21.
Zurück zum Zitat Daniel W. Biostatistics: a foundation for analysis in the health sciences (10th edition) 1999. 200–3 p. 978-1-118-30279-8. Daniel W. Biostatistics: a foundation for analysis in the health sciences (10th edition) 1999. 200–3 p. 978-1-118-30279-8.
22.
Zurück zum Zitat Nyakiba JO, Kosgei RJ, Okalebo F. The extent of medication-related problems among patients at Kenyatta National Hospital Medical Wards: A 2012 Study: University of Nairobi; 2014. Nyakiba JO, Kosgei RJ, Okalebo F. The extent of medication-related problems among patients at Kenyatta National Hospital Medical Wards: A 2012 Study: University of Nairobi; 2014.
23.
Zurück zum Zitat Sumaili EK, Cohen EP, Zinga CV, Krzesinski J-M, Pakasa NM, Nseka NM. High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo. BMC Nephrol. 2009;10:18.CrossRef Sumaili EK, Cohen EP, Zinga CV, Krzesinski J-M, Pakasa NM, Nseka NM. High prevalence of undiagnosed chronic kidney disease among at-risk population in Kinshasa, the Democratic Republic of Congo. BMC Nephrol. 2009;10:18.CrossRef
24.
Zurück zum Zitat National Kidney F. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, clasification and stratification 2002. S1-S266 p. 1-931472-10-6. National Kidney F. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, clasification and stratification 2002. S1-S266 p. 1-931472-10-6.
26.
Zurück zum Zitat Team RC. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2014. Team RC. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2014.
27.
Zurück zum Zitat AbuRuz SM, Alrashdan Y, Jarab A, Jaber D, Alawwa IA. Evaluation of the impact of pharmaceutical care service on hospitalized patients with chronic kidney disease in Jordan. Int J Clin Pharm. 2013;35(5):780–9.CrossRef AbuRuz SM, Alrashdan Y, Jarab A, Jaber D, Alawwa IA. Evaluation of the impact of pharmaceutical care service on hospitalized patients with chronic kidney disease in Jordan. Int J Clin Pharm. 2013;35(5):780–9.CrossRef
28.
Zurück zum Zitat Fraser SDS, Roderick PJ, May CR, McIntyre N, McIntyre C, Fluck RJ, et al. The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study. BMC Nephrol. 2015;16(193–03):11p. Fraser SDS, Roderick PJ, May CR, McIntyre N, McIntyre C, Fluck RJ, et al. The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study. BMC Nephrol. 2015;16(193–03):11p.
29.
Zurück zum Zitat Khdour MR, Jarab AS, Adas HO, Samaro EZ, Mukattash TL, Hallak HO. Identification of drug-related problems: a prospective study in two general hospitals. Curr Clin Pharmacol. 2012;7(4):276–81.CrossRef Khdour MR, Jarab AS, Adas HO, Samaro EZ, Mukattash TL, Hallak HO. Identification of drug-related problems: a prospective study in two general hospitals. Curr Clin Pharmacol. 2012;7(4):276–81.CrossRef
30.
Zurück zum Zitat Fox CH, Swanson A, Kahn LS, Glaser K, Murray BM. Improving chronic kidney disease care in primary care practices: an upstate New York practice-based research network (UNYNET) study. J Am Board Family Med JABFM. 2008;21(6):522–30.CrossRef Fox CH, Swanson A, Kahn LS, Glaser K, Murray BM. Improving chronic kidney disease care in primary care practices: an upstate New York practice-based research network (UNYNET) study. J Am Board Family Med JABFM. 2008;21(6):522–30.CrossRef
31.
Zurück zum Zitat Allen AS, Forman JP, Orav EJ, Bates DW, Denker BM, Sequist TD. Primary care management of chronic kidney disease. J Gen Intern Med. 2011;26(4):386–92.CrossRef Allen AS, Forman JP, Orav EJ, Bates DW, Denker BM, Sequist TD. Primary care management of chronic kidney disease. J Gen Intern Med. 2011;26(4):386–92.CrossRef
32.
Zurück zum Zitat Onyango MA, Okalebo FA, Osanjo GO, Nyamu DG. Patterns of antibiotic use and dose adjustment in patients with chronic kidney disease at Kenyatta National Hospital, Kenya. Pharmacoepidemiol Drug Saf. 2013;22:485. Onyango MA, Okalebo FA, Osanjo GO, Nyamu DG. Patterns of antibiotic use and dose adjustment in patients with chronic kidney disease at Kenyatta National Hospital, Kenya. Pharmacoepidemiol Drug Saf. 2013;22:485.
33.
Zurück zum Zitat Liew Y, Ang S, Kamis HJ, Tan J, Brennan M. Medication compliance and understanding in pre-end stage renal disease. Nephrology. 2010;15:33–4. Liew Y, Ang S, Kamis HJ, Tan J, Brennan M. Medication compliance and understanding in pre-end stage renal disease. Nephrology. 2010;15:33–4.
34.
Zurück zum Zitat Viswanathan M, Kahwati LC, Golin CE, Blalock SJ, Coker-Schwimmer E, Posey R, et al. Medication therapy management interventions in outpatient settings: a systematic review and meta-analysis. JAMA Intern Med. 2015;175(1):76–87.CrossRef Viswanathan M, Kahwati LC, Golin CE, Blalock SJ, Coker-Schwimmer E, Posey R, et al. Medication therapy management interventions in outpatient settings: a systematic review and meta-analysis. JAMA Intern Med. 2015;175(1):76–87.CrossRef
35.
Zurück zum Zitat Barnes KD, Tayal NH, Lehman AM, Beatty SJ. Pharmacist-driven renal medication dosing intervention in a primary care patient-centered medical home. Pharmacotherapy. 2014;34(12):1330–5.CrossRef Barnes KD, Tayal NH, Lehman AM, Beatty SJ. Pharmacist-driven renal medication dosing intervention in a primary care patient-centered medical home. Pharmacotherapy. 2014;34(12):1330–5.CrossRef
36.
Zurück zum Zitat Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc JAPhA. 2008;48(3):341–53. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc JAPhA. 2008;48(3):341–53.
37.
Zurück zum Zitat Isetts BJ, Schondelmeyer SW, Artz MB, Lenarz LA, Heaton AH, Wadd WB, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc JAPhA. 2008;48(2):203–11 (3 p following 11).CrossRef Isetts BJ, Schondelmeyer SW, Artz MB, Lenarz LA, Heaton AH, Wadd WB, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc JAPhA. 2008;48(2):203–11 (3 p following 11).CrossRef
Metadaten
Titel
Medication-related problems among adult chronic kidney disease patients in a sub-Saharan tertiary hospital
verfasst von
Lisper Wangeci Njeri
William Otieno Ogallo
David Gitonga Nyamu
Sylvia Adisa Opanga
Alfred Rugendo Birichi
Publikationsdatum
01.10.2018
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 5/2018
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-018-0651-7

Weitere Artikel der Ausgabe 5/2018

International Journal of Clinical Pharmacy 5/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.